Acute Myeloid Leukemia (Prognosis)

Vascular Endothelial Growth Factor Levels Predict Outcome

Published in Blood Weekly, January 20th, 2000

Cellular vascular endothelial growth factor level is an independent predictor of outcome in some patients with acute myeloid leukemia, according to researchers in the United States.

Vascular endothelial growth factor (VEGF) is a potent mitogen for vascular endothelial cells. VEGF has been associated with angiogenesis, growth, dissemination, metastasis, and poor outcome in solid tumors.

A. Aguayo and colleagues performed a study to assess cellular VEGF levels and their prognostic significance in newly diagnosed acute myeloid leukemia (AML) ("Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients with Acute Myeloid...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-01-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry